Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine injections for chronic abdominal wall pain
NCT06121466Phase 4Recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine in Anterior cutaneous nerve entrapment syndrome (ACNES), sponsored by Oregon Health & Science University. Primary endpoints: Change in abdominal wall pain at 12 weeks, Pain Catastrophizing Scale at 12 weeks and 6 more. Started Jan 2023; status: recruiting.
02
Drugs
lidocaine
03
Conditions
Anterior cutaneous nerve entrapment syndrome (ACNES)
Beyond the preview
Go deeper on NCT06121466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121466.